| 刘浩志,马智文.萨提亚模式家庭治疗对躯体形式障碍患者疗效的影响[J].四川精神卫生杂志,2014,27(1):43-45.LIU Hao - zhi,MA Zhi - wen,The effect of Satir family therapy model for patients with somatoform disorders[J].SICHUAN MENTAL HEALTH,2014,27(1):43-45 |
| 萨提亚模式家庭治疗对躯体形式障碍患者疗效的影响 |
| The effect of Satir family therapy model for patients with somatoform disorders |
| |
| DOI： |
| 中文关键词: 萨提亚模式 家庭治疗 度洛西汀 躯体形式障碍 |
| 英文关键词:Satir model Family therapy Duloxetine Somatoform disorders |
| 基金项目: |
|
| 摘要点击次数: |
| 全文下载次数: |
| 中文摘要: |
| 目的 评价萨提亚模式家庭治疗对躯体形式障碍患者疗效的影响.方法 将符合《国际疾病分类（第10版）》（ICD-10）诊断标准的48例躯体形式障碍患者随机分为研究组和对照组,研究组给予度洛西汀合并萨提亚模式家庭治疗,对照组只给予度洛西汀治疗,共观察8周.采用家庭亲密度与适应性量表（FACES Ⅱ-CV）对家庭亲密性和适应性进行测量;用汉密尔顿抑郁量表（HAMD）、汉密尔顿焦虑量表（HAMA）、症状自评量表（SCL-90）分别评定抑郁、焦虑症状和主观身体不适感.结果 ①治疗8周后,研究组和对照组显效率分别为87.5％和58.3％;有效率分别为100％,和83.3％,两组比较差异有统计学意义（P＜0.05）.②治疗8周后研究组与对照组FACES Ⅱ-CV评分[（8.1±6.9）vs.（17.7±9.1）]比较差异有统计学意义（P＜0.05）.③治疗第6、8周末,研究组与对照组SCL-90躯体化因子分、HAMD评分、HAMA评分比较差异有统计学意义（P＜0.01）.结论 合用萨提亚模式家庭治疗可能会改善躯体形式障碍患者的家庭亲密性和适应性,提高对躯体形式障碍的疗效. |
| 英文摘要: |
| Objective To evaluate the efficacy of Satir model Family Therapy on inpatients with somatoform disorders. Methods 48 patients with somatoform disorders diagnosed by the ICD - 10 diagnostic criteria were randomly divided into research group and control group; the study group were given Satir model family therapy combined duloxetine and other drug treatment, whike the control group were only given duloxetine and other drugs for treatment, both two groups were observed for 8 weeks. Applying family cohesion and adaptability Scale （ FACES II - CV） to assess family intimacy and adaptability effects ; Meanwhile Hamilton Depression Scale （HAMD）, Hamilton Anxiety Scale （HAMA）, SCL -90 somatization scale regularly evaluating the effection. Results （1）After 8 weeks of treatment, significant efficiency of the study group was 87.5 % ,while the control group was 58.3% ;and effectiveness of study group was 100% , however, 83.3 % in the control group, and there were statistically significant difference between two groups （P 〈 0.05 ）. （2）After 8 weeks treatment, FACES II - CV score of two groups were significantly different （ P 〈 0. 05 ）. （3）At the end of treatment of 6, 8 week, the study group shown significant differences compared with control group, （ P 〈 0.01 ）. Conclusion Satir model family therapy might improve the efficacy in patients with somatoform disorders, and improve the patient family intimacy and adaptability. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|